it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.. https://oakley-sunglassesformen.us/Bernas-daughter-of-Mehlman-from-Manotick?Sweaneyfa=148 .... . . .. august 2009 (18)